Open Medicine
(Jun 2018)
MMP-2 and TIMP-2 in patients with heart failure and chronic kidney disease
Kobusiak-Prokopowicz Malgorzata,
Krzysztofik Justyna,
Kaaz Konrad,
Jolda-Mydlowska Beata,
Mysiak Andrzej
Affiliations
Kobusiak-Prokopowicz Malgorzata
Wroclaw Medical University, Cardiology Department, ul. Borowska 213, 50-556Wroclaw, Poland, Tel. +48 71 736 42 00, Fax: +48 71 736 42 09
Krzysztofik Justyna
Wroclaw Medical University, Cardiology Department, Wroclaw, Poland
Kaaz Konrad
Wroclaw Medical University, Cardiology Department, Wroclaw, Poland
Jolda-Mydlowska Beata
Wroclaw Medical University, Cardiology Department, Wroclaw, Poland
Mysiak Andrzej
Wroclaw Medical University, Cardiology Department, Wroclaw, Poland
DOI
https://doi.org/10.1515/med-2018-0037
Journal volume & issue
Vol. 13,
no. 1
pp.
237
– 246
Abstract
Read online
The aim of the study was to assess MMP-2 (matrix metalloproteinase-2) and TIMP-2 (tissue inhibitor of metalloproteinase-2) serum levels in patients with diverse types of heart failure (HF) and chronic kidney disease (CKD).
Keywords
WeChat QR code
Close